Genus plc

GENSFOTCHealthcare● Active

$31.07

+$0.00(+0.00%)

Market Cap$2.1B

P/E Ratio—

52W High$37.25

52W Low$26.01

Avg Volume24

Open$35.00

Beta0.90

Free Cash Flow Financials Revenue

Genus plc (GENSF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GENSF · free cash flow · updated Jun 15, 2026

Core FCF metrics

GENSF · FCF · TTM · margin & CAGR

Free cash flow was $48.6M for FY2025 (fiscal year ending 2025-06-30), up 852.9% year-over-year The FCF margin was 7.2%. Five-year CAGR stands at +6.5%.

FY2025 Free Cash Flow$48.6M▲ +852.9% YoY

Trailing 12M (TTM)$75.2Mtrailing 4 quarters sum

FCF Margin7.2%$48.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGR+6.5%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GENSF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$67.2M(19M)$48.6M▲ +852.9%7.2%

FY2024$29.8M(25M)$5.1M▼ 66.4%0.8%

FY2023$50.4M(35M)$15.2M▲ +294.9%2.2%

FY2022$34.3M(42M)−$7.8M▼ 120.1%-1.3%

FY2021$67.5M(29M)$38.8M▲ +9.3%6.8%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GENSF · P/FCF · FCF yield · FCF per share

Genus plc (GENSF) trades at a FCF yield of 3.92% and a price-to-free-cash-flow ratio of 27.3x. FCF per share stands at $1.14, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.92%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.14

TTM FCF ÷ Shares Outstanding

Price / FCF

x27.3

Share Price ÷ FCF per Share

EV / FCF (TTM)

x29.6

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

GENSF · cash flow statement · operating / investing / financing

For FY2025, Genus plc generated $67.2M in operating cash flow and spent 19M in capital expenditures, yielding $48.6M in free cash flow.

Operating Activities

+$67.2M

Cash from core business operations

2025-06-30

Investing Activities

−$13.8M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$46.6M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($67.2M) − |CapEx| (19M) = FCF ($48.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GENSF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Genus plcYOU

GENSF

$48.6M+852.9%7.2%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Genus plc (GENSF) reported free cash flow of $48.6M for FY2025 (fiscal year ending 2025-06-30), up 852.9% year-over-year. The FCF margin was 7.2%.

Based on available data, Genus plc has maintained positive free cash flow for at least 14 fiscal year(s). FCF peaked at $48.6M in FY2025. The 5-year CAGR stands at +6.5%.

Genus plc's FCF yield is 3.92% and price-to-FCF ratio is 27.3x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GENSF free cash flow · 8 questions

Genus plc free cash flow was $48.6M for FY2025, up 852.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $75.2M.

GENSF free cash flowGENSF FCFGENSF FCF 2025GENSF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Genus plc · Genus plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026